Every Thursday we send out a curated newsletter on “all things femtech”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
Endomag’s technologies use non-invasive magnetic sensing to locate and stage breast cancer and have helped over 130,000 women across the world receive more precise and less invasive cancer treatment.
Highlights
UK-based Breast Cancer Technology Company Endomag secures £15M in Series D Funding; K’ept Health wins HITLAB’s Women’s Health Tech Challenge; Nasdaq seeks mandatory board diversity for listed companies; EHE Health partners with femtech startup Wildflower Health to launch their new app for maternal & family health; Babyscripts adds 3 new board members; Cara Delevigne joins sextech startup Lora DiCarlo as Co-Owner & Creative Advisor; Dame Hilda Lloyd Network, a new group promoting multidisciplinary research in women’s health, launches in the UK; 3 femtech startups join Techstars & Barclays’ new “Female Founders First” accelerator; Applications for Paris-based STATION F’s femtech accelerator are open until Dec 15
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.
